Receive our newsletter – data, insights and analysis delivered to you
  1. Analysis
October 27, 2021updated 25 Oct 2021 5:04pm

Africa has seen the largest growth in central nervous system related trials over the past decade

We've analysed 10 years' worth of clinical trials data from GlobalData to pick out key geographic trends.

By GlobalData Healthcare

Africa has seen a 306% increase in the number of central nervous system trials taking place over the past decade, the largest increase for any region worldwide.

The region now ranks in first for the total number of trials taking place, compared to its sixth placed ranking in 2010.

These figures come from GlobalData’s extensive clinical trials database which seeks to track the number of clinical trials taking place in countries around the world, in numerous therapy areas.

Africa

Africa saw the biggest increase in central nervous system related trials.

Between 2010 and 2020, there was a 306% increase in the number of trials taking place.

In 2020, the largest proportion of trials in the region took place in Egypt with 87.7% of all trials in the region taking place there.

Tunisia and South Africa had the next largest percentage of trials taking place in the region with 4.6% and 3.1%, respectively.

Asia-Pacific

The Asia-Pacific region saw a 107% increase in the number of central nervous system trials taking place.

China saw the largest amount of trials taking place, in 2020, at 46.7%.

Trials in India and Australia also made up a large proportion of the trials taking place with 20.5% and 8.1%, respectively.

Middle East

The Middle East saw a 34% increase in the number trials taking place.

Iran, Israel and Saudi Arabia made up the most trials in the region, with 82.4%, 10.7% and 2.9%, respectively.

Europe

Europe saw a 14% decrease in central nervous system related trials taking place.

Russia saw the largest percentage of trials taking place in the region at 7.7%.

Spain and Germany also made up a significant proportion of the trials taking place.

North America

North America saw a decrease in the number of central nervous system trials.

The region saw a 15% decrease in the number of trials.

The United States made up 85.2% the largest proportion of trials taking place in the region.

Canada and Mexico also made up a large amount of the trials taking place with 12.5% and 2.4%, respectively.

South and Central America

South and Central America saw the biggest decrease in central nervous system trials.

The number of trials in the region fell by 36% between 2010 and 2020.

Brazil saw the largest percentage of trials taking place in the region with 46.5%.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU